The stuff I take for hypertension costs me $2 per tab, once a day. (Were I blowing off my insurance coverage, it would be somewhere between $2 and $3.) Needless to say, it’s a name-brand drug, and it will be on patent at least through 2011, so I can hardly wait for it to show up in generic form at Target for $4 for thirty tabs.
Then again, maybe not:
I am aghast at the latest headline spin insisting that generic drugs are just as good as the more expensive brands.
Why? Because the study cited doesn’t “prove” that at all. The “survey” was not a survey of actual drugs taken randomly from your local pharmacy, but a “survey” of articles that examined generic versus brand name medicines.
The problem? This means that “headsup” articles, where medications were caught being a problem and were taken off the market, aren’t included.
Nor is that the only problem:
[D]o your generics come from a long established company, that would face lawsuits, loss of their good name, and even bankruptcy for peddling fake ingredients, or does the generic come from a “fly by night” company whose owners can take the money and run?
Of course, with globalization, even well known drug companies in the US and Europe are using ingredients or using factories in third world countries.
I looked to see who’d gotten approval for the generic version of my antihypertensive, and that firm (there’s only the one, so far) has been around nearly as long as I have, which suggests that maybe I’m not running that big a risk by trying to save $56 a month.